Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 106

Results For "PATH"

1375 News Found

ENTOD Pharmaceuticals gets DCGI nod to carry out the phase 3 trials of 0.05% atropine eye drops
Drug Approval | June 01, 2022

ENTOD Pharmaceuticals gets DCGI nod to carry out the phase 3 trials of 0.05% atropine eye drops

Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children


Thyrocare unveils new brand identity
News | June 01, 2022

Thyrocare unveils new brand identity

New logo reflects Thyrocare’s transformation since 1996 to its current leading position at the cutting edge of Diagnostic services


All India Institute of Ayurveda launches #YogaSeAyu campaign for International Day of Yoga 2022
Healthcare | May 29, 2022

All India Institute of Ayurveda launches #YogaSeAyu campaign for International Day of Yoga 2022

The campaign aims to promote an integrated view by combining Ayurveda and Yoga to create harmony not just within the body, but also in our minds


Lancet publishes results of Phase 3 programmes of Rinvoq in Ulcerative Colitis
Biotech | May 27, 2022

Lancet publishes results of Phase 3 programmes of Rinvoq in Ulcerative Colitis

Data from the three studies formed the basis of the company's application for approval by regulatory agencies


Lumenis OptiLight wins 2022 MedTech Breakthrough Award
News | May 26, 2022

Lumenis OptiLight wins 2022 MedTech Breakthrough Award

For the third straight year, Lumenis wins an award recognizing outstanding medical companies and technologies


ASG Eye Hospitals opens unit in Dombivli, Maharashtra
Hospitals | May 26, 2022

ASG Eye Hospitals opens unit in Dombivli, Maharashtra

The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra


European Commission approves Keytruda plus chemotherapy as neoadjuvant treatment for breast cancer
Drug Approval | May 25, 2022

European Commission approves Keytruda plus chemotherapy as neoadjuvant treatment for breast cancer

This Keytruda combination is the first immunotherapy option approved in the EU for high-risk early-stage TNBC


Fitelo unveils new branding after Pre-Series A fund-raise
Startup | May 25, 2022

Fitelo unveils new branding after Pre-Series A fund-raise

Each member of Fitelo's team of experts gives highly personalized attention and recommendations to their clients ensuring they reach their fitness goals holis


Pfizer offers patent-protected medicines on not-for-profit to 45 low income countries
News | May 25, 2022

Pfizer offers patent-protected medicines on not-for-profit to 45 low income countries

Pfizer calls upon global health leaders and organizations to join the Accord, bringing their expertise and resources to close the health equity gap